4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,160.00p
   
  • Change Today:
      15.00p
  • 52 Week High: 1,188.00p
  • 52 Week Low: 500.00p
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 2,186
  • Market Cap: £148.54m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,252,453 £14,528,455
Joseph Manuel Fernández 448,244 £5,199,630
David John Roth 316,000 £3,665,600
Maria Del Pilar de la Huerta 6,667 £77,337
Hansjörg Plaggemars 6,667 £77,337
Timothy Paul McCarthy 2,388 £27,701

Major Shareholders

Notifier** Holding Value*
DELPHI Unternehmensberatung AG 6,604,357 £76,610,541
Wilhelm K. T. Zours 6,604,357 £76,610,541
Deutsche Balaton AG 5,965,921 £69,204,684
4bb AG 3,665,242 £42,516,807
2invest AG 3,665,242 £42,516,807
Sparta AG 1,351,718 £15,679,929

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,160.00p
Change Today 15.00p
% Change 1.31 %
52 Week High 1,188.00p
52 Week Low 500.00p
Volume 2,186
Shares Issued 12.81m
Market Cap £148.54m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
98.61% above the market average98.61% above the market average98.61% above the market average98.61% above the market average98.61% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
34.57% below the market average34.57% below the market average34.57% below the market average34.57% below the market average34.57% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

4basebio Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
16:19 1,184 @ 1,188.00p
14:13 771 @ 1,166.00p
14:24 146 @ 1,188.00p
12:37 32 @ 1,158.50p
12:22 43 @ 1,158.50p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page